Question 1

What are Intracranial Aneurysms?

Accepted Answer

An intracranial aneurysm or a cerebral aneurysm is an abnormal focal dilation of a brain artery due to the weakening of the inner muscular layer of a blood vessel wall. The vessel develops a ""blister-like"" dilation that can become thin and rupture without warning.

Question 2

What is the market for Global Intracranial Aneurysms?

Accepted Answer

The global intracranial aneurysms market was valued at USD 1.13 billion in 2021, growing at a CAGR of 9.10% during the forecast period from 2022 to 2027, to reach USD 1.90 billion by 2027.

Question 3

What are the drivers for the Global Intracranial Aneurysms?

Accepted Answer

The major factors driving the demand for Intracranial Aneurysms are the increasing prevalence of brain aneurysms and arteriovenous malformations (AVMs) owing to sedentary lifestyles. Moreover, an increase in high blood pressure among the population, approval, and launch of various intracranial aneurysm treatment devices, and rising research and development activities for the development of intracranial aneurysm treatment devices, among others are anticipated to bolster the global intracranial aneurysm market.

Question 4

What are the key players operating in Global Intracranial Aneurysms?

Accepted Answer

Some of the key market players operating in the Intracranial Aneurysms market include Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co.Ltd., Lepu Medical Technology(Beijing)Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., KANEKA CORPORATION,  and others.

Question 5

Which region has the highest share in the Intracranial Aneurysms market?

Accepted Answer

Among all the regions, North America is expected to occupy a major share in the overall Intracranial Aneurysms market during the forecasted period. This domination is because of the exponentially rising prevalence of the target population in the region. Furthermore, the recent launch of intracranial aneurysm treatment products, the presence of key manufacturers, and the presence of well-established healthcare and reimbursement facilities in the region are anticipated to propel the intracranial aneurysm market.